The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $2.37 in the prior trading day, Geron Corp (NASDAQ: GERN) closed at $1.61, down -32.07%. In other words, the price has decreased by -$32.07 from its previous closing price. On the day, 93.31 million shares were traded.
Ratios:
Our goal is to gain a better understanding of GERN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.74 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.05.
On November 05, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 08 ’24 when GRETHLEIN ANDREW J sold 674,348 shares for $4.56 per share. The transaction valued at 3,073,004 led to the insider holds 0 shares of the business.
Feller Faye sold 287,900 shares of GERN for $1,334,129 on Jun 10 ’24. The EVP, Chief Medical Officer now owns 0 shares after completing the transaction at $4.63 per share. On Jun 10 ’24, another insider, Kapur Anil, who serves as the EVP, Corp Strategy & CCO of the company, sold 421,875 shares for $4.64 each. As a result, the insider received 1,959,609 and left with 0 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 33.01 while its Price-to-Book (P/B) ratio in mrq is 3.32.
Stock Price History:
Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -47.64%, while the 200-Day Moving Average is calculated to be -59.65%.
Shares Statistics:
A total of 603.10M shares are outstanding, with a floating share count of 567.45M. Insiders hold about 6.13% of the company’s shares, while institutions hold 75.67% stake in the company.
Earnings Estimates
Geron Corp (GERN) is currently under the scrutiny of 3.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.02, with high estimates of $0.0 and low estimates of -$0.04.
Analysts are recommending an EPS of between $0.0 and -$0.15 for the fiscal current year, implying an average EPS of -$0.07. EPS for the following year is $0.16, with 2.0 analysts recommending between $0.19 and $0.12.
Revenue Estimates
5 analysts predict $50.36M in revenue for the current quarter. It ranges from a high estimate of $53.2M to a low estimate of $48.25M. As of the current estimate, Geron Corp’s year-ago sales were $304kFor the next quarter, 5 analysts are estimating revenue of $56.73M. There is a high estimate of $62.3M for the next quarter, whereas the lowest estimate is $50.66M.
A total of 6 analysts have provided revenue estimates for GERN’s current fiscal year. The highest revenue estimate was $266.3M, while the lowest revenue estimate was $209.68M, resulting in an average revenue estimate of $245.44M. In the same quarter a year ago, actual revenue was $76.99MBased on 6 analysts’ estimates, the company’s revenue will be $425.95M in the next fiscal year. The high estimate is $590.06M and the low estimate is $265.93M.
